Is This The Reason That Omeros Corporation Fell 17.7% in April?

What: Shareholders of Omeros Corporation , a Seattle based biopharmaceutical company, had an April to forget as the company's stock shed more than 17% of its value during the month,according to data from S&P Global Market Intelligence .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.